MIT-Harvard NanoMedical Consortium
The MIT-Harvard NanoMedical Consortium is collaboration among MIT, Harvard University, Harvard Medical School, Massachusetts General Hospital, and Brigham and Women’s Hospital. It is one of seven Centers of Cancer Nanotechnology Excellence awarded by the The National Cancer Institute (NCI), part of the National Institutes of Health (NIH). It focuses on developing a diversified portfolio of nanoscale devices for targeted delivery of cancer therapies, diagnostics, non-invasive imaging, and molecular sensing. In addition to general oncology applications, the Consortium focuses on prostate, brain, lung, ovarian, and colon cancer. Examples of projects that the Consortium is undertaking include the development of:
- Targeted nanoparticles for treating prostate cancer
- Polymer nanoparticles and quantum dots for siRNA delivery
- Next-generation magnetic nanoparticles for multimodal, non-invasive tumor imaging
- Implantable, biodegradable microelectromechanical systems (MEMS), also known as lab-on-a-chip devices, for in vivo molecular sensing of tumor-associated biomolecules
- Low-toxicity nanocrystal quantum dots for biomedical sensing
In addition to drawing on the scientific and technological expertise of its investigators, the Consortium uses available facilities for toxicology testing and the extensive mouse models of cancer collection at the collaborating institutions.
Project and Core Abstracts are available online:
NCI Alliance for Nanotechnology in Cancer, MIT-Harvard CCNE
Monthly Presentations for CCNE members (password protected):
CMIR Nanotechnology Program
Principal Investigators:
Robert Langer, Ph.D.
Institute Professor
Massachusetts Institute of Technology
Ralph Weissleder, M.D., Ph.D.
Professor Harvard Medical School;
Director, Center for Molecular Imaging Research
Harvard University, Massachusetts General Hospital
In The News:
HST device draws cells close--but not too close--together
April 4, 2007
Team develops nanoparticles to battle cancer
February 1, 2007
The Boston Herald: Tiny implants could offer huge insights on cancer
January 14, 2007
2006
Scientific American names Angela Belcher Researcher of the Year
November 6 , 2006
Colleagues honor Langer for 30 years of innovation
July 20, 2006
MIT nanoparticles may help detect, treat tumors
May 1, 2006
Nanoparticles armed to combat cancer
April 10, 2006
2005
Nanotechnology grabs headlines
Video broadcast of Greater Boston television program
December 27, 2005
Shrinking the war on cancer
October 31, 2005
MIT chosen for national role fighting cancer
October 4, 2005
Langer talk highlights cancer symposium
June 30, 2005
